Eric Van Cutsem
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020/03/20 by Ghassan K Abou-Alfa, Ghassan K. Abou‐Alfa, Vaibhav Sahai +26 · 10 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cholangiocarcinoma and Gallbladder Cancer Studies #Fibroblast Growth Factor Research #IgG4-Related and Inflammatory Diseases
- Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline
2019/02/05 by Cesare Hassan, Piotr Wysocki, Lorenzo Fuccio +24 · 23 citations
Medicine · #Colorectal Cancer Screening and Detection #Gastric Cancer Management and Outcomes #Colorectal Cancer Surgical Treatments
- Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023/04/15 by Kohei Shitara, Florian Lordick, Yung-Jue Bang +25 · 5 citations
Medicine · Neuroscience · #Barrier Structure and Function Studies #Esophageal Cancer Research and Treatment #MRI in cancer diagnosis
- Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
2024/11/27 by Thierry André, Elena Élez, Eric Van Cutsem +24 · 1 voice · 2 citations
Medicine · #Cancer Immunotherapy and Biomarkers #Genetic factors in colorectal cancer #Colorectal Cancer Treatments and Studies